BioCentury | Oct 22, 2019
Emerging Company Profile

Intrepida: Tackling the innate immune system to treat cancer

...newco. Martin was CEO of Altair Therapeutics Inc. and Cebix Inc., and is CEO of Dauntless Pharmaceuticals Inc....
BioCentury | Jul 29, 2017
Finance

Going with the flow

...2) . Also in February, Canaan led a $32 million series A for reformulation company Dauntless Pharmaceuticals Inc....
BioCentury | Feb 25, 2017
Finance

Intranasal option

...non-invasive somatostatin analog, prompting the VC to lead a $25 million series A extension for Dauntless Pharmaceuticals Inc....
...up to $825 million. Sofinnova also was a co-investor in both companies. - Virginia Li Virginia Li Dauntless Pharmaceuticals Inc. acromegaly Canaan...
BioCentury | Feb 24, 2017
Clinical News

DB1038: Ph I started

...to reference data on safety and efficacy from scientific literature or from previously approved products. Dauntless Pharmaceuticals Inc....
...growth hormone concentrations and insulin-like growth factor-1 (IGF-1) concentrations Status: Phase I started Milestone: NA Nora Weintraub Dauntless Pharmaceuticals Inc. Growth...
BioCentury | Feb 17, 2017
Financial News

Dauntless adds $25M to series A round

...of octreotide acetate which uses drug delivery technology from Aegis Therapeutics LLC (San Diego, Calif.). Chris Lieu DP1038 Dauntless Pharmaceuticals Inc....
BioCentury | Feb 17, 2017
Financial News

Dauntless Pharmaceuticals completes venture financing

...On Feb. 16, Dauntless Pharmaceuticals Inc. (San Diego, Calif.) raised $25 million in an extension of its series...
...therapeutic is under development to treat acromegaly and neuroendocrine tumors. Dauntless Pharmaceuticals Inc. , San Diego, Calif. Alicia Parker Dauntless Pharmaceuticals Inc....
BioCentury | Aug 24, 2015
Company News

Aegis Therapeutics, Dauntless Pharmaceuticals deal

...The partners said financial terms are not disclosed. Aegis Therapeutics LLC , San Diego, Calif. Dauntless Pharmaceuticals Inc....
BioCentury | Jul 27, 2015
Finance

Gestalt of the times

...Sofinnova Ventures is jumping on the asset-centric bandwagon with the creation of Dauntless Pharmaceuticals Inc. While the model...
BioCentury | Jul 27, 2015
Financial News

Dauntless Pharmaceuticals completes venture financing

Dauntless Pharmaceuticals Inc. , San Diego, Calif. Business: Cancer Date completed: 2015-07-21 Type: Venture financing Raised: $12 million Investor: Sofinnova Ventures WIR Staff...
BioCentury | Jul 22, 2015
Financial News

Dauntless raises $12M series A

...Asset-centric company Dauntless Pharmaceuticals Inc. (San Diego, Calif.) made its debut on Tuesday with a $12 million series...
Items per page:
1 - 10 of 10
BioCentury | Oct 22, 2019
Emerging Company Profile

Intrepida: Tackling the innate immune system to treat cancer

...newco. Martin was CEO of Altair Therapeutics Inc. and Cebix Inc., and is CEO of Dauntless Pharmaceuticals Inc....
BioCentury | Jul 29, 2017
Finance

Going with the flow

...2) . Also in February, Canaan led a $32 million series A for reformulation company Dauntless Pharmaceuticals Inc....
BioCentury | Feb 25, 2017
Finance

Intranasal option

...non-invasive somatostatin analog, prompting the VC to lead a $25 million series A extension for Dauntless Pharmaceuticals Inc....
...up to $825 million. Sofinnova also was a co-investor in both companies. - Virginia Li Virginia Li Dauntless Pharmaceuticals Inc. acromegaly Canaan...
BioCentury | Feb 24, 2017
Clinical News

DB1038: Ph I started

...to reference data on safety and efficacy from scientific literature or from previously approved products. Dauntless Pharmaceuticals Inc....
...growth hormone concentrations and insulin-like growth factor-1 (IGF-1) concentrations Status: Phase I started Milestone: NA Nora Weintraub Dauntless Pharmaceuticals Inc. Growth...
BioCentury | Feb 17, 2017
Financial News

Dauntless adds $25M to series A round

...of octreotide acetate which uses drug delivery technology from Aegis Therapeutics LLC (San Diego, Calif.). Chris Lieu DP1038 Dauntless Pharmaceuticals Inc....
BioCentury | Feb 17, 2017
Financial News

Dauntless Pharmaceuticals completes venture financing

...On Feb. 16, Dauntless Pharmaceuticals Inc. (San Diego, Calif.) raised $25 million in an extension of its series...
...therapeutic is under development to treat acromegaly and neuroendocrine tumors. Dauntless Pharmaceuticals Inc. , San Diego, Calif. Alicia Parker Dauntless Pharmaceuticals Inc....
BioCentury | Aug 24, 2015
Company News

Aegis Therapeutics, Dauntless Pharmaceuticals deal

...The partners said financial terms are not disclosed. Aegis Therapeutics LLC , San Diego, Calif. Dauntless Pharmaceuticals Inc....
BioCentury | Jul 27, 2015
Finance

Gestalt of the times

...Sofinnova Ventures is jumping on the asset-centric bandwagon with the creation of Dauntless Pharmaceuticals Inc. While the model...
BioCentury | Jul 27, 2015
Financial News

Dauntless Pharmaceuticals completes venture financing

Dauntless Pharmaceuticals Inc. , San Diego, Calif. Business: Cancer Date completed: 2015-07-21 Type: Venture financing Raised: $12 million Investor: Sofinnova Ventures WIR Staff...
BioCentury | Jul 22, 2015
Financial News

Dauntless raises $12M series A

...Asset-centric company Dauntless Pharmaceuticals Inc. (San Diego, Calif.) made its debut on Tuesday with a $12 million series...
Items per page:
1 - 10 of 10